SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants

Clinical trial NCT06453824 · COMPLETED

Trial details

NCT number: NCT06453824
Sponsor: MDI Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety and Tolerability

Start date: 2024-05-17
Primary completion: 2024-11-11
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.